4,5-Disubstituted cis-pyrrolidinones as inhibitors of type II 17β-hydroxysteroid dehydrogenase. Part 3. Identification of lead candidate
Jill E. Wood(Bayer (United States)), Cedo M. Bagi(Bayer (United States)), Christiana Akuche(Bayer (United States)), Antonietta Bacchiocchi(Bayer (United States)), Jeremy L. Baryza(Bayer (United States)), Marie‐Luise Blue(Bayer (United States)), Catherine A. Brennan(Bayer (United States)), Ann-Marie Campbell(Bayer (United States)), Soongyu Choi(Bayer (United States)), James H. Cook(Bayer (United States)), Patricia J. Conrad(Bayer (United States)), Brian R. Dixon(Bayer (United States)), Paul Ehrlich(Bayer (United States)), Todd Gane(Bayer (United States)), David Gunn(Bayer (United States)), Ted Joe(Bayer (United States)), Jeffrey S. Johnson(Bayer (United States)), Jerold Jordan(Bayer (United States)), Richard H. Kramss(Bayer (United States)), Peiying Liu(Bayer (United States)), Joan Levy(Bayer (United States)), Derek Lowe(Bayer (United States)), Ian McAlexander(Bayer (United States)), Reina Natero(Bayer (United States)), Anikó M. Redman(Bayer (United States)), William J. Scott(Bayer (United States)), Christopher Town(Bayer (United States)), Ming Wang(Bayer (United States)), Yamin Wang(Bayer (United States)), Zhonghua Zhang(Bayer (United States))
Cited by 28Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis